Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Short Interest Down 14.2% in January

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) was the target of a large decline in short interest during the month of January. As of January 15th, there was short interest totaling 1,276 shares, a decline of 14.2% from the December 31st total of 1,487 shares. Based on an average daily volume of 5,917 shares, the short-interest ratio is presently 0.2 days. Based on an average daily volume of 5,917 shares, the short-interest ratio is presently 0.2 days.

Analysts Set New Price Targets

CZMWY has been the topic of a number of research analyst reports. The Goldman Sachs Group lowered Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a report on Tuesday, January 20th. Sanford C. Bernstein cut Carl Zeiss Meditec to a “market perform” rating in a research report on Monday, January 26th. One equities research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold”.

Carl Zeiss Meditec Stock Performance

Shares of CZMWY opened at $32.37 on Wednesday. The stock’s 50-day moving average price is $45.37 and its 200 day moving average price is $49.56. Carl Zeiss Meditec has a 12-month low of $32.34 and a 12-month high of $76.28.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.